Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tuberculosis drug targets.

Ying Zhang1, L Mario Amzel

  • 1Department of Molecular Microbiology and Immunology, Bloomberg, School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA. yzhang@jhsph.edu

Current Drug Targets
|April 18, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sodium/Iodide Symporter Metastable Intermediates Provide Insights into Conformational Transition between Principal Thermodynamic States.

The journal of physical chemistry. B·2023
Same author

Structural insights into the mechanism of the sodium/iodide symporter.

Nature·2022
Same author

Class I PI3K Biology.

Current topics in microbiology and immunology·2022
Same author

Development of high-affinity nanobodies specific for Na<sub>V</sub>1.4 and Na<sub>V</sub>1.5 voltage-gated sodium channel isoforms.

The Journal of biological chemistry·2022
Same author

Cyclodextrin Modulated Type I Collagen Self-Assembly to Engineer Biomimetic Cornea Implants.

Advanced functional materials·2021
Same author

In Structural Glycobiology, Deuterium provides the Details.

Structure (London, England : 1993)·2021

New anti-tuberculosis (TB) drugs are urgently needed due to rising drug-resistant TB. Novel drug candidates targeting Mycobacterium tuberculosis persistence and virulence aim to shorten therapy and combat resistance.

Area of Science:

  • Microbiology
  • Drug Discovery
  • Infectious Diseases

Background:

  • Tuberculosis (TB) remains a major global health threat, with increasing drug-resistant strains complicating treatment.
  • Current chemotherapy is lengthy and challenged by persistent Mycobacterium tuberculosis, necessitating new therapeutic strategies.

Purpose of the Study:

  • To identify novel drug candidates and intervention targets for developing new anti-tuberculosis drugs.
  • To address the urgent need for effective treatments against drug-resistant TB and shorten therapy duration.

Main Methods:

  • Leveraging advances in mycobacterial biology and genomics for target identification.
  • Utilizing functional genomics (microarray, proteomics) and modern drug design approaches (structure-based design, combinatorial chemistry).

Related Experiment Videos

Main Results:

  • Identification of potential drug targets in essential mycobacterial processes like metabolism, persistence, virulence, and cell wall synthesis.
  • Exploration of novel drug candidates based on these identified targets.

Conclusions:

  • New anti-TB drugs targeting novel pathways are essential to overcome drug resistance and reduce treatment length.
  • Integrating systems biology with advanced drug design holds promise for developing next-generation TB therapies.